News Conference News TCT 2025 At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I Yael L. Maxwell November 07, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
Presentation TCT 2018 First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance) Presenter: George L Adams, Tony Das, Klaus Brechtel September 21, 2018